PeptidePedia The community reference

Contributions of ChainCustodyChad

User contributions·51 logged edits·page 1 of 1

Contributions by ChainCustodyChad, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 3,411 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 18,573 ±0 add category for suppliers in China
  2. 06:12, 11 Jul 2026 (diff | hist) Limit of detection 4,865 ±0 add the forced-degradation conditions the claim rests on
  3. 06:29, 17 Jun 2026 (diff | hist) Sangon Biotech 14,764 ±0 convert the product range to a table so the documentation column lines up
  4. 13:40, 4 Jun 2026 (diff | hist) Talk:Grey market 748 +131 /* Unknown is not bad */ reply
  5. 03:23, 18 May 2026 (diff | hist) Weight regain after discontinuation 4,670 ±0 expand §Interpretation
  6. 18:24, 16 May 2026 (diff | hist) Qingdao Saber Technology Pharmaceutical 14,592 ±0 state which lines are held in regional stock
  7. 09:50, 30 Apr 2026 (diff | hist) Talk:Deamidation 537 +190 /* Storage versus manufacture */ new section
  8. 13:50, 22 Apr 2026 (diff | hist) Talk:Cold-chain freight 748 +145 /* Robustness of the dry solid */ reply
  9. 10:50, 8 Apr 2026 (diff | hist) SinoPep 18,360 +220 label the reception tally as weak, self-selected evidence at this point of use
  10. 22:26, 4 Apr 2026 (diff | hist) PolyPeptide Group (Hangzhou) 18,363 ±0 correct the other-designations row — those are trading variants, not subsidiaries
  11. 10:40, 6 Feb 2026 (diff | hist) Sigma-Aldrich (Shanghai) Trading 18,421 ±0 state what the certificate supplied with orders carries
  12. 11:33, 3 Feb 2026 (diff | hist) Zhuhai Kerui Biotechnology 14,491 +1,086 attribute the capability claim to the organisation's own material
  13. 09:00, 16 Jan 2026 (diff | hist) Talk:Chain of custody 822 +96 /* Asymmetry of uncontrolled results */ reply
  14. 10:10, 15 Jan 2026 (diff | hist) Talk:Chain of custody 400 +211 /* Asymmetry of uncontrolled results */ new section
  15. 13:48, 3 Jan 2026 (diff | hist) Guangzhou JEEP Biotechnology 15,452 +220 sentence case in headings per PP:MOS
  16. 02:33, 22 Dec 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 17,288 +1,024 rm the comparison with another supplier; there is no common basis for it
  17. 18:53, 14 Dec 2025 (diff | hist) PolyPeptide Group (Hangzhou) 12,571 +913 correct the regional-warehouse list — six sites, not five
  18. 00:59, 3 Dec 2025 (diff | hist) PolyPeptide Group (Hangzhou) 11,658 +259 m British spelling per PP:MOS
  19. 20:10, 23 Nov 2025 (diff | hist) Shanghai ERP Biotechnology 9,285 +485 attribute the documentation description to the purchaser reports it comes from
  20. 00:07, 26 Oct 2025 (diff | hist) Wuhan Wansheng Biotechnology 15,849 +220 expand §Operations and documentation practice
  21. 20:33, 12 Oct 2025 (diff | hist) Nantong Guangyuan Chemical 14,641 +220 m expand §Reception
  22. 00:36, 8 Oct 2025 (diff | hist) GenScript Peptides 7,275 +159 clarify that a registered business scope is a licensing fact, not a quality assurance
  23. 05:14, 17 Sep 2025 (diff | hist) GenScript Peptides 4,213 +229 attribute the documentation description to the purchaser reports it comes from
  24. 19:59, 7 Sep 2025 (diff | hist) Shenzhen Hybio Pharmaceutical 4,733 +1,190 state which lines are held in regional stock
  25. 08:57, 27 Aug 2025 (diff | hist) Cold chain 24,029 ±0 add the collapse-temperature point, sourced
  26. 21:11, 8 Aug 2025 (diff | hist) Shanghai ERP Biotechnology 4,020 +33 add the storage and handling guidance the organisation publishes
  27. 10:37, 8 Aug 2025 (diff | hist) Chinese Peptide Company 13,887 +798 m add the minimum order quantity for custom synthesis
  28. 21:14, 4 Aug 2025 (diff | hist) SinoPep 5,978 +995 ce per PP:MOS
  29. 08:44, 1 Jul 2025 (diff | hist) Talk:Blind sampling 1,096 +162 /* Anonymous ordering: does it count as blinding? */ reply
  30. 01:30, 20 May 2025 (diff | hist) Counterfeit peptide 4,235 ±0 expand §Substitution
  31. 12:25, 3 May 2025 (diff | hist) Chinese Peptide Company 11,801 +968 add the transit window each regional warehouse serves
  32. 22:17, 6 Apr 2025 (diff | hist) Wuhan Wansheng Biotechnology 10,253 ±0 m add the note that this wiki publishes no score and no league table
  33. 09:15, 28 Mar 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,374 +38 expand §External links
  34. 19:18, 26 Mar 2025 (diff | hist) Certificate of analysis 6,972 ±0 correct the description of the sampling procedure
  35. 00:40, 16 Mar 2025 (diff | hist) Batch number 3,708 ±0 British spelling per PP:MOS
  36. 23:44, 18 Feb 2025 (diff | hist) Medutest 3,795 ±0 fix a dangling clause
  37. 22:38, 16 Feb 2025 (diff | hist) Sangon Biotech 5,302 +301 copyedit
  38. 08:16, 3 Feb 2025 (diff | hist) GL Biochem (Shanghai) 10,312 +733 expand §External links
  39. 08:47, 16 Jan 2025 (diff | hist) Talk:Certificate of analysis 959 +178 /* The seven-field table */ reply
  40. 13:03, 4 Jan 2025 (diff | hist) Albumin binding half-life extension 4,401 +45 expand §Physical basis
  41. 22:15, 25 Dec 2024 (diff | hist) Growth hormone secretagogue 2,721 ±0 expand §Material in research supply
  42. 07:33, 28 Nov 2024 (diff | hist) Hypoglycaemia 3,334 +844 m add the contraindication with its rationale
  43. 10:38, 7 Nov 2024 (diff | hist) Guangzhou JEEP Biotechnology 7,184 +1,812 convert the product range to a table so the documentation column lines up
  44. 04:50, 30 Oct 2024 (diff | hist) Nantong Guangyuan Chemical 6,249 +372 add category for suppliers in China
  45. 08:29, 22 Oct 2024 (diff | hist) Talk:Blind sampling 822 +136 /* Is "almost no" defensible without a count? */ reply
  46. 05:50, 1 Oct 2024 (diff | hist) Chain of custody 2,414 ±0 add the note that a purity figure without water and counterion is not a mass
  47. 11:01, 17 Sep 2024 (diff | hist) Qingdao Sigma Chemical 2,804 +592 add the lead time for catalogue lines, as reported
  48. 19:03, 30 Aug 2024 (diff | hist) Qingdao Sigma Chemical 2,174 +427 m expand §Ordering and availability
  49. 02:08, 26 Aug 2024 (diff | hist) Certificate of analysis 1,858 ±0 split §What a report shows from §What it does not
  50. 17:00, 8 Aug 2024 (diff | hist) Proglucagon 2,238 ±0 m distinguish the active and total forms of the hormone throughout
  51. 09:00, 30 Jun 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 1,312 +1,312 N create article — adverse-effect stub